Price
CHART BY
Frequently asked questions
What is DNA X, Inc.'s market capitalization?
The market capitalization of DNA X, Inc. is $5.21M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for DNA X, Inc.?
DNA X, Inc.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$177.67. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for DNA X, Inc.'s stock?
Currently, 2 analysts cover DNA X, Inc.'s stock, with a consensus target price of $144.00. Analyst ratings provide insights into the stock's expected performance.
What is DNA X, Inc.'s revenue over the trailing twelve months?
Over the trailing twelve months, DNA X, Inc. reported a revenue of $59.11M.
What is the EBITDA for DNA X, Inc.?
DNA X, Inc.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$27.71M. EBITDA measures the company's overall financial performance.
What is the free cash flow of DNA X, Inc.?
DNA X, Inc. has a free cash flow of -$26.04M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does DNA X, Inc. have, and what sector and industry does it belong to?
DNA X, Inc. employs approximately 160 people. It operates in the Information Technology sector, specifically within the Telecommunications Equipment industry.
What is the free float of DNA X, Inc.'s shares?
The free float of DNA X, Inc. is 945.11K. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $5.21M
- EPS (TTM)
- -$177.67
- Free Float
- 945.11K
- Revenue (TTM)
- $59.11M
- EBITDA (TTM)
- -$27.71M
- Free Cashflow (TTM)
- -$26.04M
Pricing
- 52W span
- $2.62$38.52
Analyst Ratings
The price target is $144.00 and the stock is covered by 2 analysts.
Buy
1
Hold
1
Sell
0
Information
DNA X, Inc. engages in the provision of rugged and consumer durable mobile devices including phones and accessories designed to provide extra protection for users that demand more durability. It operates through the following geographical segments: the United States, Canada and Latin America, Europe and Middle East, and Asia Pacific. The company was founded by Ram Chandran, Isaac Eteminan, Anush Gopalan, Jai Kumar, Sudu Srinivasan, and Joakim Wiklund on August 5, 1999 and is headquartered in San Diego, CA.
- Employees
- 160
- Industries
- Telecommunications Equipment
- Sector
- Information Technology
Identifier
- Primary Ticker
- SONM
Fundamentals & EOD data from FactSet